Baxter International

Three leading biotech companies will step into the earnings spotlight this week. Consensus forecasts from Wall Street analysts call for earnings growth from just two of them. And only one of them has topped estimates by double-digits in recent quarters. While the biotechnology industry has had a...

Short interest in a number of stocks surged in the most recent settlement period. Two health care stocks were among those leading that trend in the first weeks of May. The number of shares short in one of them doubled for the second period in a row. It does not appear that short sellers have "...

Short interest in a number of stocks surged in the most recent settlement period. Two healthcare stocks were among those leading that trend in the final weeks of April. Shares of both rose in the period, but only one held on to that gain. With the markets surging last month and the S&P 500...

The three largest biotechs are set to share their latest quarterly results this week. Wall Street analysts are looking for solid to strong growth from all three. However, expectations are lower for many other biotech and pharmaceutical companies reporting this week. The three largest public...

Pharmaceutical giants Merck & Co., Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE) are expected to post quarterly results this week. Analysts are looking for different top and bottom line results from each. A few other pharmaceutical and biotech companies are on deck this week as well. Two of...

U.S. stocks were slightly lower as positive labor market data clashed with fourth quarter GDP estimates that showed the economic expanded less than economists had expected. Major indices finished slightly lower as the Nasdaq index continues to see its losses fall sharper compared to the Dow and...

U.S. stocks rose as investors focused on positive economic data rather than the tense situation in Ukraine. Economic reports showed that U.S. industrial production rose in February. President Obama imposed sanctions against Russian and Crimea officials following an election on Sunday which...

Declining short interest in Alexion Pharmaceuticals (NASDAQ: ALXN) and Pharmacyclics (NASDAQ: PCYC) bucked the trend among leading biotech and emerging pharmaceutical companies between the August 15 and August 30 settlement dates. The number of shares sold short in Amgen (NASDAQ: AMGN), Biogen...

Some smaller health care companies saw unusual movement in their stocks on Friday. And not just in Anacor Pharmaceuticals (NASDAQ: ANAC), Halozyme Therapeutics (NASDAQ: HALO), Puma Biotechnology (NYSE: PBYI) and Questcor Pharmaceuticals (NASDAQ: QCOR), which are discussed below. But also ACADIA...

The short interest in biotech and emerging pharmaceutical companies was mixed again in the first two weeks of February. The number of shares sold short in Arena Pharmaceuticals (NASDAQ: ARNA), Illumina (NASDAQ: ILMN) and Vertex Pharmaceuticals (NASDAQ: VRTX) grew somewhat between the January 31...

It is not unusual for stocks on a tear to the overrun their mean price targets, which is a signal of how far analysts on average expect the share price to climb. Many of the top performing dividend payers in the health care sector over the past six months, such as Eli Lilly (NYSE: LLY) and PDL...